Shan Sha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shan Sha has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Kailang Mu
College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China
4 shared publications - Changmao Guo
College of Pharmaceutical Sciences, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China
2 shared publications - Qiumei Luo
School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Blumea Research Center of Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China
2 shared publications - Shi Yao
School of Pharmacy, Guizhou University of Traditional Chinese Medicine, Blumea Research Center of Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China
2 shared publications - Tianyu Tang
College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China
2 shared publications - Yuxin Pang
College of Pharmacy, Guizhou University of Traditional Chinese Medicine, Guiyang 550025, China
2 shared publications
Latest Publications
- Open Access
Integrated Transcriptome and Proteome Analysis Provides Insights into the Mechanism of Blumea balsamifera in Response to Drought Stress
Drought severely restricts the growth and secondary metabolism of medicinal plants. Blumea balsamifera is a water-sensitive and economically important medicinal species, yet its molecular regulatory mechanisms in response to drought remain largely unclear, which is worthy of in-depth investigation. In this study, four-month-old B. balsamifera seedlings were subjected to three treatments; normal irrigation (CK), drought stress (DS), and rehydration recovery (RW). Leaf photosynthetic parameters, L-Borneol content, and root physiological indices were determined, and transcriptomic and proteomic analyses were integrated to explore its drought response mechanism. Under drought stress, leaf net photosynthetic rate, transpiration rate, and stomatal conductance decreased sharply, while intercellular CO2 concentration increased; L-Borneol content showed a biphasic change, and root malondialdehyde content accumulated continuously, accompanied by significant increases in antioxidant enzyme activities and osmotic regulator contents. A total of 9917 differentially expressed genes and 736 differentially expressed proteins were identified, which were mainly enriched in phenylpropanoid biosynthesis, photosynthesis and other pathways, with photosynthesis-related genes and proteins coordinately downregulated. B. balsamifera adapts to drought stress by activating the antioxidant defense system, regulating osmotic substances, and reprogramming photosynthetic networks. The key candidate genes obtained provide important targets for drought-tolerant breeding of this species, and their reliability was verified by RT-qPCR.
Open AccessIntegrated Transcriptome and Proteome Analysis Provides Insights into the Mechanism of Blumea balsamifera in Response to Drought Stress
Drought severely restricts the growth and secondary metabolism of medicinal plants. Blumea balsamifera is a water-sensitive and economically important medicinal species, yet its molecular regulatory mechanisms in response to drought remain largely unclear, which is worthy of in-depth investigation. In this study, four-month-old B. balsamifera seedlings were subjected to three treatments; normal irrigation (CK), drought stress (DS), and rehydration recovery (RW). Leaf photosynthetic parameters, L-Borneol content, and root physiological indices were determined, and transcriptomic and proteomic analyses were integrated to explore its drought response mechanism. Under drought stress, leaf net photosynthetic rate, transpiration rate, and stomatal conductance decreased sharply, while intercellular CO2 concentration increased; L-Borneol content showed a biphasic change, and root malondialdehyde content accumulated continuously, accompanied by significant increases in antioxidant enzyme activities and osmotic regulator contents. A total of 9917 differentially expressed genes and 736 differentially expressed proteins were identified, which were mainly enriched in phenylpropanoid biosynthesis, photosynthesis and other pathways, with photosynthesis-related genes and proteins coordinately downregulated. B. balsamifera adapts to drought stress by activating the antioxidant defense system, regulating osmotic substances, and reprogramming photosynthetic networks. The key candidate genes obtained provide important targets for drought-tolerant breeding of this species, and their reliability was verified by RT-qPCR.
- Open Access
- 25 February 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (3) , 359
Blumea balsamifera Alleviates Rheumatoid Arthritis by Suppressing Synovial Inflammation via the PI3K/AKT Signaling Pathway: From Chemical Profiling to Molecular Mechanism
Background/Objectives: Blumea balsamifera (L.) DC. (Miao Medicine: Diangd vob bvid), a medicinal plant with a long ethnopharmacological history in Southwest China, is widely used by the Miao, Li, and Zhuang ethnic groups to treat rheumatic diseases. While previous studies indicated that the ethyl acetate fraction of B. balsamifera (BBEA) possesses potent anti-inflammatory properties, its specific bioactive material basis and the underlying molecular mechanisms against rheumatoid arthritis (RA) remain elusive. Methods: In this study, an integrated strategy combining chemical profiling, network pharmacology, and experimental validation was employed. First, UPLC-Q-Exactive-MS/MS analysis was conducted to characterize the chemical constituents of BBEA. Subsequently, network pharmacology and molecular docking were utilized to predict potential active compounds and core signaling pathways. Finally, the therapeutic effects and mechanisms were validated in vivo using a collagen-induced arthritis (CIA) rat model and in vitro using lipopolysaccharide (LPS)-induced RAW264.7 macrophages. Results: A total of 25 active constituents, including Genkwanin and Luteolin, were identified in BBEA via UPLC-Q-Exactive-MS/MS. Network pharmacology analysis predicted that the PI3K/AKT signaling pathway is critical for BBEA’s anti-RA activity, and molecular docking confirmed strong binding affinities between key components (e.g., Genkwanin) and core targets (SRC, AKT1). In vivo experiments demonstrated that BBEA significantly reduced the Arthritis Index (AI) and paw swelling, reversed weight loss, and ameliorated synovial hyperplasia in CIA rats (p < 0.05). Furthermore, BBEA markedly downregulated the levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-17) both in serum and synovial tissues. Mechanistically, Western blot analysis verified that BBEA inhibited the phosphorylation of PI3K and AKT in a dose-dependent manner. Conclusions: This study systematically reveals that BBEA alleviates RA symptoms and synovial inflammation primarily by inhibiting the PI3K/AKT signaling pathway. These findings provide a scientific basis for the traditional application of B. balsamifera and suggest BBEA as a promising candidate for RA therapy.
- 25 February 2026
- Published by MDPI AG in Pharmaceuticals
- Vol. 19 (3) , 359
Open AccessBlumea balsamifera Alleviates Rheumatoid Arthritis by Suppressing Synovial Inflammation via the PI3K/AKT Signaling Pathway: From Chemical Profiling to Molecular Mechanism
Background/Objectives: Blumea balsamifera (L.) DC. (Miao Medicine: Diangd vob bvid), a medicinal plant with a long ethnopharmacological history in Southwest China, is widely used by the Miao, Li, and Zhuang ethnic groups to treat rheumatic diseases. While previous studies indicated that the ethyl acetate fraction of B. balsamifera (BBEA) possesses potent anti-inflammatory properties, its specific bioactive material basis and the underlying molecular mechanisms against rheumatoid arthritis (RA) remain elusive. Methods: In this study, an integrated strategy combining chemical profiling, network pharmacology, and experimental validation was employed. First, UPLC-Q-Exactive-MS/MS analysis was conducted to characterize the chemical constituents of BBEA. Subsequently, network pharmacology and molecular docking were utilized to predict potential active compounds and core signaling pathways. Finally, the therapeutic effects and mechanisms were validated in vivo using a collagen-induced arthritis (CIA) rat model and in vitro using lipopolysaccharide (LPS)-induced RAW264.7 macrophages. Results: A total of 25 active constituents, including Genkwanin and Luteolin, were identified in BBEA via UPLC-Q-Exactive-MS/MS. Network pharmacology analysis predicted that the PI3K/AKT signaling pathway is critical for BBEA’s anti-RA activity, and molecular docking confirmed strong binding affinities between key components (e.g., Genkwanin) and core targets (SRC, AKT1). In vivo experiments demonstrated that BBEA significantly reduced the Arthritis Index (AI) and paw swelling, reversed weight loss, and ameliorated synovial hyperplasia in CIA rats (p < 0.05). Furthermore, BBEA markedly downregulated the levels of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-17) both in serum and synovial tissues. Mechanistically, Western blot analysis verified that BBEA inhibited the phosphorylation of PI3K and AKT in a dose-dependent manner. Conclusions: This study systematically reveals that BBEA alleviates RA symptoms and synovial inflammation primarily by inhibiting the PI3K/AKT signaling pathway. These findings provide a scientific basis for the traditional application of B. balsamifera and suggest BBEA as a promising candidate for RA therapy.
- Open Access
- 7 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 1621
Exogenous Methyl Jasmonate Enhances Chemical Defense in Blumea balsamifera Against Spodoptera litura by Boosting Phenylpropanoid and Flavonoid Metabolism
Blumea balsamifera (L.) DC. is the primary source plant of natural borneol, an important ethnic medicine in China. But its quality and yield are severely threatened by the polyphagous pest Spodoptera litura Fabricius during cultivation. In order to elucidate the mechanism of the chemical defense response induced by methyl jasmonate (MeJA) in B. balsamifera plants against S. litura. This study investigated the MeJA-mediated chemical defense in B. balsamifera against S. litura by integrating insect bioassays, enzymatic analysis, and metabolomics. Results demonstrated that exogenous MeJA application significantly inhibited larval feeding preference and consumption, suppressed relative growth rates, and reduced pupal weights. Physiologically, MeJA treatment rapidly upregulated the activities of jasmonic acid (JA) biosynthetic and antioxidant enzymes. Crucially, metabolomic profiling revealed that MeJA triggered a metabolic reconfiguration, specifically promoting the accumulation of defensive secondary metabolites. Notably, key bioactive compounds, including secoisolariciresinol diglucoside and isochlorogenic acid C, were significantly enriched alongside elevated endogenous JA levels. These findings suggest that MeJA enhances the resistance of B. balsamifera not merely by activating enzymatic defense but by reprogramming the phenylpropanoid and phenolic metabolic pathways. The above results indicate that exogenous MeJA can induce the activation of the chemical defense system in B. balsamifera plants and enhance their resistance to S. litura.
- 7 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 1621
Open AccessExogenous Methyl Jasmonate Enhances Chemical Defense in Blumea balsamifera Against Spodoptera litura by Boosting Phenylpropanoid and Flavonoid Metabolism
Blumea balsamifera (L.) DC. is the primary source plant of natural borneol, an important ethnic medicine in China. But its quality and yield are severely threatened by the polyphagous pest Spodoptera litura Fabricius during cultivation. In order to elucidate the mechanism of the chemical defense response induced by methyl jasmonate (MeJA) in B. balsamifera plants against S. litura. This study investigated the MeJA-mediated chemical defense in B. balsamifera against S. litura by integrating insect bioassays, enzymatic analysis, and metabolomics. Results demonstrated that exogenous MeJA application significantly inhibited larval feeding preference and consumption, suppressed relative growth rates, and reduced pupal weights. Physiologically, MeJA treatment rapidly upregulated the activities of jasmonic acid (JA) biosynthetic and antioxidant enzymes. Crucially, metabolomic profiling revealed that MeJA triggered a metabolic reconfiguration, specifically promoting the accumulation of defensive secondary metabolites. Notably, key bioactive compounds, including secoisolariciresinol diglucoside and isochlorogenic acid C, were significantly enriched alongside elevated endogenous JA levels. These findings suggest that MeJA enhances the resistance of B. balsamifera not merely by activating enzymatic defense but by reprogramming the phenylpropanoid and phenolic metabolic pathways. The above results indicate that exogenous MeJA can induce the activation of the chemical defense system in B. balsamifera plants and enhance their resistance to S. litura.
- Open Access
- 6 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (15) , 7610
Genome-Wide Identification and Characterisation of the 4-Coumarate–CoA Ligase (4CL) Gene Family in Gastrodia elata and Their Transcriptional Response to Fungal Infection
Gastrodia elata Blume is an important medicinal orchid, yet its large-scale cultivation is increasingly threatened by fungal diseases. The 4-coumarate–CoA ligase (4CL) gene family directs a key step in phenylpropanoid metabolism and plant defence, but its composition and function in G. elata have not been investigated. We mined the G. elata genome for 4CL homologues, mapped their chromosomal locations, and analysed their gene structures, conserved motifs, phylogenetic relationships, promoter cis-elements and codon usage bias. Publicly available transcriptomes were used to examine tissue-specific expression and responses to fungal infection. Subcellular localisation of selected proteins was verified by transient expression in Arabidopsis protoplasts. Fourteen Ge4CL genes were identified and grouped into three clades. Two members, Ge4CL2 and Ge4CL5, were strongly upregulated in tubers challenged with fungal pathogens. Ge4CL2 localised to the nucleus, whereas Ge4CL5 localised to both the nucleus and the cytoplasm. Codon usage analysis suggested that Escherichia coli and Oryza sativa are suitable heterologous hosts for Ge4CL expression. This study provides the first genome-wide catalogue of 4CL genes in G. elata and suggests that Ge4CL2 and Ge4CL5 may participate in antifungal defence, although functional confirmation is still required. The dataset furnishes a foundation for functional characterisation and the molecular breeding of disease-resistant G. elata cultivars.
- 6 August 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (15) , 7610
Open AccessGenome-Wide Identification and Characterisation of the 4-Coumarate–CoA Ligase (4CL) Gene Family in Gastrodia elata and Their Transcriptional Response to Fungal Infection
Gastrodia elata Blume is an important medicinal orchid, yet its large-scale cultivation is increasingly threatened by fungal diseases. The 4-coumarate–CoA ligase (4CL) gene family directs a key step in phenylpropanoid metabolism and plant defence, but its composition and function in G. elata have not been investigated. We mined the G. elata genome for 4CL homologues, mapped their chromosomal locations, and analysed their gene structures, conserved motifs, phylogenetic relationships, promoter cis-elements and codon usage bias. Publicly available transcriptomes were used to examine tissue-specific expression and responses to fungal infection. Subcellular localisation of selected proteins was verified by transient expression in Arabidopsis protoplasts. Fourteen Ge4CL genes were identified and grouped into three clades. Two members, Ge4CL2 and Ge4CL5, were strongly upregulated in tubers challenged with fungal pathogens. Ge4CL2 localised to the nucleus, whereas Ge4CL5 localised to both the nucleus and the cytoplasm. Codon usage analysis suggested that Escherichia coli and Oryza sativa are suitable heterologous hosts for Ge4CL expression. This study provides the first genome-wide catalogue of 4CL genes in G. elata and suggests that Ge4CL2 and Ge4CL5 may participate in antifungal defence, although functional confirmation is still required. The dataset furnishes a foundation for functional characterisation and the molecular breeding of disease-resistant G. elata cultivars.